(VIANEWS) - Verra Mobility Corporation (VRRM), Fresenius Medical Care AG (FMS), Huntington Bancshares (HBAN) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Verra Mobility Corporation (VRRM)
36.3% sales growth and 3.21% return on equity
Verra Mobility Corporation offers smart mobility solutions and services throughout the United States and Canada.
Verra Mobility Corporation's sales growth this year is anticipated to be 28.4% and 4.2% for next year.
Year-on-year quarterly revenue growth grew by 67.3%, now sitting on 480.77M for the twelve trailing months.
Volume
Today's last reported volume for Verra Mobility Corporation is 1064400 which is 15.01% above its average volume of 925485.
Verra Mobility Corporation's sales growth is a negative 0% for the ongoing quarter and 36.3% for the next. The company's growth estimates for the ongoing quarter and the next is 75% and 140%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.21%.
Volatility
Verra Mobility Corporation's last day, last week, and last month's current intraday variation average was 2.64%, 2.46%, and 1.98%, respectively.
Verra Mobility Corporation's highest amplitude of average volatility was 5.14% (day), 6.00% (last week), and 4.46% (last month), respectively.
Verra Mobility Corporation's Stock Yearly Top and Bottom Value
Verra Mobility Corporation's stock is valued at $14.38 at 11:22 EST, way below its 52-week high of $18.13 and above its 52-week low of $13.40.
Verra Mobility Corporation's Moving Average
Verra Mobility Corporation's value is below its 50-day moving average of $15.94 and under its 200-day moving average of $15.45.2. Fresenius Medical Care AG (FMS)
27.6% sales growth and 9.51% return on equity
Fresenius Medical Care AG & Co. KGaA is a company that provides kidney dialysis services and related services. It also offers other healthcare services internationally.
Fresenius Medical Care AG's sales growth this year is anticipated to be 19.2% and 4.6% for next year.
Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.
Volume
Today's last reported volume for Fresenius Medical Care AG is 296668 which is 43.7% below its average volume of 526941.
Fresenius Medical Care AG's sales growth for the next quarter is 27.6%. The company's growth estimates for the ongoing quarter and the next is a negative 26% and negative -24.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.51%.
Volatility
Fresenius Medical Care AG's last day, last week, and last month's current intraday variation average was 2.53%, 1.15%, and 1.52%, respectively.
Fresenius Medical Care AG's highest amplitude of average volatility was 1.21% (day), 1.68% (last week), and 1.67% (last month), respectively.
Fresenius Medical Care AG's Stock Yearly Top and Bottom Value
Fresenius Medical Care AG's stock is valued at $30.48 at 11:22 EST, way below its 52-week high of $43.33 and higher than its 52-week low of $29.71.
Fresenius Medical Care AG's Moving Average
Fresenius Medical Care AG's value is under its 50-day moving average of $33.36 and way under its 200-day moving average of $37.59.3. Huntington Bancshares (HBAN)
20.3% sales growth and 8.03% return on equity
Huntington Bancshares Incorporated is a holding firm for Huntington National Bank. It provides mortgage, commercial and small-business banking services.
Huntington Bancshares's sales growth this year is expected to be 24.7% and 12.8% for next year.
Year-on-year quarterly revenue growth grew by 51.2%, now sitting on 5.96B for the twelve trailing months.
Volume
Today's last reported volume for Huntington Bancshares is 3772040 which is 70.23% below its average volume of 12671300.
Huntington Bancshares's sales growth for the next quarter is 20.3%. The company's growth estimates for the present quarter and the next is 22.2% and negative -33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.03%.
Volatility
Huntington Bancshares's last day, last week, and last month's current intraday variation average was 1.73%, 1.39%, and 1.37%, respectively.
Huntington Bancshares's highest amplitude of average volatility was 2.79% (day), 2.91% (last week), and 3.03% (last month), respectively.
Huntington Bancshares's Stock Yearly Top and Bottom Value
Huntington Bancshares's stock is valued at $13.56 at 11:22 EST, way below its 52-week high of $17.79 and higher than its 52-week low of $13.01.
Huntington Bancshares's Moving Average
Huntington Bancshares's value is under its 50-day moving average of $14.57 and way under its 200-day moving average of $15.28.4. Advanced Semiconductor Engineering (ASX)
17.7% sales growth and 19.23% return on equity
ASE Technology Holding Co., Ltd.
Advanced Semiconductor Engineering's sales growth this year is expected to be 22.9% and 10.1% for next year.
Year-on-year quarterly revenue growth grew by 22.3%, now sitting on 545.94B for the twelve trailing months.
Volume
Today's last reported volume for Advanced Semiconductor Engineering is 1389740 which is 78.56% below its average volume of 6482420.
Advanced Semiconductor Engineering's sales growth for the next quarter is 17.7%. The company's growth estimates for the ongoing quarter and the next is 43.8% and 28.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.23%.
Volatility
Advanced Semiconductor Engineering's last day, last week, and last month's current intraday variation average was 1.14%, 3.38%, and 2.11%, respectively.
Advanced Semiconductor Engineering's highest amplitude of average volatility was 3.29% (day), 3.91% (last week), and 3.28% (last month), respectively.
Advanced Semiconductor Engineering's Stock Yearly Top and Bottom Value
Advanced Semiconductor Engineering's stock is valued at $6.57 at 11:22 EST, way below its 52-week high of $9.62 and above its 52-week low of $6.20.
Advanced Semiconductor Engineering's Moving Average
Advanced Semiconductor Engineering's worth is under its 50-day moving average of $7.06 and way below its 200-day moving average of $7.68.5. On Assignment (ASGN)
8.6% sales growth and 13.43% return on equity
ASGN Incorporated offers professional staffing services and IT solutions across the life science, technology, and digital fields. It is available in both the commercial and public sectors of the United States as well internationally.
On Assignment's sales growth this year is anticipated to be 11.8% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 17%, now sitting on 4.01B for the twelve trailing months.
Volume
Today's last reported volume for On Assignment is 16772 which is 91.8% below its average volume of 204724.
On Assignment's sales growth for the next quarter is 8.6%. The company's growth estimates for the ongoing quarter and the next is 22% and 5.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.43%.
Volatility
On Assignment's last day, last week, and last month's current intraday variation average was 5.61%, 2.77%, and 1.71%, respectively.
On Assignment's highest amplitude of average volatility was 3.84% (day), 3.24% (last week), and 2.49% (last month), respectively.
On Assignment's Stock Yearly Top and Bottom Value
On Assignment's stock is valued at $116.69 at 11:22 EST, way below its 52-week high of $131.89 and way higher than its 52-week low of $91.61.